UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pioneer of prostate cancer: past, present and the future of FOXA1

Protein & cell, 2021, Vol.12 (1), p.29-38

2021

Volltextzugriff (PDF)

Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19

Cell, 2018-07, Vol.174 (3), p.564-575.e18

2018

Volltextzugriff (PDF)

GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer

Nature communications, 2020-08, Vol.11 (1), p.4205-12, Article 4205

2020

Volltextzugriff (PDF)

TMPRSS2–ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer

Nature genetics, 2017-09, Vol.49 (9), p.1336-1345

2017

Volltextzugriff (PDF)

A chemical toolbox for the study of bromodomains and epigenetic signaling

Nature communications, 2019-04, Vol.10 (1), p.1915-14, Article 1915

2019

Volltextzugriff (PDF)

The Transition from Quiescent to Activated States in Human Hematopoietic Stem Cells Is Governed by Dynamic 3D Genome Reorganization

Cell stem cell, 2021-03, Vol.28 (3), p.488-501.e10

2021

Volltextzugriff (PDF)

Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate Tumors

Cancer cell, 2019-12, Vol.36 (6), p.674-689.e6

2019

Volltextzugriff (PDF)

Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer

Nature communications, 2020-01, Vol.11 (1), p.441-13, Article 441

2020

Volltextzugriff (PDF)

CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer

Nature communications, 2021-03, Vol.12 (1), p.1781-15, Article 1781

2021

Volltextzugriff (PDF)

301 Preclinical development of AB-2100, a PSMA neovasculature-inducible CA9 CAR resistant to FASL and TGFb mediated suppression for the treatment of ccRCC

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A344-A344

2023

Volltextzugriff (PDF)

Emergence of the Noncoding Cancer Genome: A Target of Genetic and Epigenetic Alterations

Cancer discovery, 2016-11, Vol.6 (11), p.1215-1229

2016

Volltextzugriff (PDF)

Chronic hypoxia favours adoption to a castration-resistant cell state in prostate cancer

Oncogene, 2023-05, Vol.42 (21), p.1693-1703

2023

Volltextzugriff (PDF)

Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus

Cellular & molecular immunology, 2016-03, Vol.13 (2), p.180-190

2016

Volltextzugriff (PDF)

Development of AB-2100, an autologous integrated circuit T (ICT) cell therapy targeting CA9 intended for the treatment of ccRCC

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.472-472

2024

Volltextzugriff (PDF)

Abstract LB092: Identification of target antigens for logic-gated CAR-T therapeutics for the treatment of clear cell renal cell carcinoma: conditional targeting of CA9 with a PSMA PrimeR

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.LB092-LB092

2023

Volltextzugriff (PDF)

An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression

Cancer research (Chicago, Ill.), 2024-09, Vol.84 (18), p.3086-3100

2024

Volltextzugriff (PDF)

Reorganization of the 3D Genome Pinpoints Noncoding Drivers of Primary Prostate Tumors

Cancer research (Chicago, Ill.), 2021-12, Vol.81 (23), p.5833-5848

2021

Volltextzugriff (PDF)

Transposable Elements Are Co-opted as Oncogenic Regulatory Elements by Lineage-Specific Transcription Factors in Prostate Cancer

Cancer discovery, 2023-11, Vol.13 (11), p.2470-2487

2023

Volltextzugriff (PDF)

Abstract B037: AB-2100, a PSMA-inducible CA9-specific CAR T cell product intended for the treatment of ccRCC provides long-term tumor responses in preclinical mouse model

Cancer immunology research, 2024-10, Vol.12 (10_Supplement), p.B037-B037

2024

Volltextzugriff (PDF)

Impact of Noncoding Genetic Alterations on the Cis-Regulatory Networks of Prostate Cancer

Zhou, Stanley Zhen Jian

2020

Volltextzugriff (PDF)

Abstract LB196: An atlas of accessible chromatin in advanced prostate cancer

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.LB196-LB196

2024

Volltextzugriff (PDF)

Abstract 38: AB-2100, a PSMA-inducible CA9-specific CAR T cell product for the treatment of ccRCC provides long-term tumor responses in preclinical mouse model

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.38-38

2024

Volltextzugriff (PDF)

Abstract 1768: Multiplexed shRNA cassettes targeting orthogonal pathways (FAS/PTPN2/TGFBR) enhance the potency of integrated circuit T cells (ICTs) in multiple solid tumor models

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.1768-1768

2023

Volltextzugriff (PDF)

How often are you taking a history and the patient complains about their care?

Pharmacy Growth, Research, Innovation and Training, 2018-10, Vol.2 (3)

Zhou, Stanley

2018

Volltextzugriff (PDF)

1 – 25 von 783

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(676)
Mit Volltextzugriff
(689)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(782)

Erscheinungsjahr

n.n

Thema

Science & Technology
(536)
Life Sciences & Biomedicine
(278)
Humans
(185)
Technology
(166)
Physical Sciences
(127)
Animals
(113)
Computer Science
(95)
Exact Sciences And Technology
(87)
Applied Sciences
(85)
Computer Science, Information Systems
(82)
Computer Science, Theory & Methods
(79)
Software
(79)
Male
(78)
Computer Science; Control Theory; Systems
(74)
Information Systems. Data Bases
(74)
Memory Organisation. Data Processing
(74)
Female
(72)
Science & Technology - Other Topics
(71)
Mice
(58)
Biological And Medical Sciences
(56)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Pioneer of prostate cancer: past, present and the future of FOXA1

Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19

GLUT1 inhibition blocks growth of RB1-positive triple negative breast cancer

TMPRSS2–ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer

A chemical toolbox for the study of bromodomains and epigenetic signaling

The Transition from Quiescent to Activated States in Human Hematopoietic Stem Cells Is Governed by Dynamic 3D Genome Reorganization

Cistrome Partitioning Reveals Convergence of Somatic Mutations and Risk Variants on Master Transcription Regulators in Primary Prostate Tumors

Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer

CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer

301 Preclinical development of AB-2100, a PSMA neovasculature-inducible CA9 CAR resistant to FASL and TGFb mediated suppression for the treatment of ccRCC

Emergence of the Noncoding Cancer Genome: A Target of Genetic and Epigenetic Alterations

Chronic hypoxia favours adoption to a castration-resistant cell state in prostate cancer

Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus

Development of AB-2100, an autologous integrated circuit T (ICT) cell therapy targeting CA9 intended for the treatment of ccRCC

Abstract LB092: Identification of target antigens for logic-gated CAR-T therapeutics for the treatment of clear cell renal cell carcinoma: conditional targeting of CA9 with a PSMA PrimeR

An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression

Reorganization of the 3D Genome Pinpoints Noncoding Drivers of Primary Prostate Tumors

Transposable Elements Are Co-opted as Oncogenic Regulatory Elements by Lineage-Specific Transcription Factors in Prostate Cancer

Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer

Abstract B037: AB-2100, a PSMA-inducible CA9-specific CAR T cell product intended for the treatment of ccRCC provides long-term tumor responses in preclinical mouse model

Impact of Noncoding Genetic Alterations on the Cis-Regulatory Networks of Prostate Cancer

Abstract LB196: An atlas of accessible chromatin in advanced prostate cancer

Abstract 38: AB-2100, a PSMA-inducible CA9-specific CAR T cell product for the treatment of ccRCC provides long-term tumor responses in preclinical mouse model

Abstract 1768: Multiplexed shRNA cassettes targeting orthogonal pathways (FAS/PTPN2/TGFBR) enhance the potency of integrated circuit T cells (ICTs) in multiple solid tumor models

How often are you taking a history and the patient complains about their care?

Suchergebnisse filtern